PEPTIDE AI / A PERSONAL LAB FOR IDEAS
Hi, I’m Ruochi (Richard) Zhang.
AIDD Director at Syneron Bio. I explore how AI can help us learn peptide representations, explore peptide design, and ask better scientific questions.
FOLLOW THE THREADS
Research, things I build, and the notes that make room for the next idea.
PepDDG, PepLand, and PepHarmony: learning across peptide sequences, structures, and function.
See selected work ↗02 / ProjectsPublic perspectives on agentic AI and the feedback between models, design, and experiments.
Inside the workshop ↗03 / LifeA notebook for travel and films, with room for real stories as I write them.
Open the notebook ↗AGENTIC RESEARCH PLAYGROUND
Try a fictional peptide mission. Watch a plan meet evidence, hit a snag, reflect, and evaluate an isolated workflow revision.
Selected public updates, grouped by origin. Company announcements describe company developments.
Syneron Bio announced a $150 million Series B financing to advance its Synova macrocyclic peptide discovery platform and support its pipeline’s progression toward clinical development.
Read original source ↗Source: Syneron BioSyneron Bio announced nearly $100 million across its Series A and A+ financing rounds. This is a company financing announcement.
Read original source ↗Source: Syneron BioSyneron Bio announced a strategic collaboration with AstraZeneca on macrocyclic peptide therapies for chronic diseases. The announcement does not establish clinical efficacy.
Read original source ↗Source: Syneron BioRuochi Zhang was a member of the Feng Ya team recognized for a fair-diagnosis proposal on maternal morbidity, demonstrated through stillbirth prediction.
Read original source ↗Team roster & project ↗Source: NIH / NICHD